FOR IMMEDIATE RELEASE
Round 15: Now Accepting Pre-Applications for the Harm Reduction Future Fund
Contact: D. D’Ontace Keyes
communications@aidsunited.org
WASHINGTON, D.C. – AIDS United’s Harm Reduction team is now accepting pre-applications for grant round 15. The Harm Reduction Futures Fund (formerly the Syringe Access Fund) is a collaborative grantmaking initiative that seeks to reduce the health, psychosocial, and socioeconomic disparities experienced by people who use drugs (PWUD).
For over 20 years, the Harm Reduction Futures Fund has invested in evidence-based and community-driven approaches to prevent the transmission of both HIV and viral hepatitis, reduce injection-related injuries, increase overdose prevention and reversal efforts, and connect people who use drugs to comprehensive prevention, treatment, and support services.
The Harm Reduction Futures Fund is seeking to award seven to fifteen (7-15) cash grants to three kinds of organizations:
-Direct Service organizations are invited to submit proposals for $10,000 to $25,000 for one year. (AU anticipates 5-13 programs will receive funding)
-Multi-program support organizations are invited to submit proposals for $25,000 to $40,000 for one year. (AU anticipates 1 program will receive funding)
-Harm Reduction organizations with Advocacy projects are invited to submit proposals for $10,000 to $25,000 for one year. (AU anticipates 1 program will receive funding)
In Round 15, the Harm Reduction Futures Fund will prioritize support for programs that are led by and serve Black, Indigenous, and other People of Color (BIPOC) and those in jurisdictions of high need and low resources. Other compelling factors may include the leadership of current or former sex workers; prevalence of HIV, viral hepatitis, and other blood-borne pathogens in a community; injection drug use prevalence, opioid use, overdose incidence; availability of local funding, and areas in which policy improvement can have local, state, and/or national impact.
The Harm Reduction Futures Fund application process will begin with a pre-application survey, which should be submitted via AIDS United’s online application form and are due by 5:00 p.m. ET on August 22, 2024. A community-based review committee will evaluate all pre-application survey submissions and invite up to forty (40) applicants to submit a full proposal. Please visit this link to review the full proposal request for more information.
For key dates and deadlines, see below:
August 1, 2024 | Request for Pre-Application Surveys Released |
August 13, 2024 | Pre-Application Survey TA Webinar at 1:00pm EST |
August 22, 2024` | Pre-Application Survey Due at 5:00 p.m. EST |
September 20, 2024 | Notification of Full Proposal Invitation Decisions |
October 3, 2024 | Request for Proposals TA Webinar |
October 24, 2024 | Full Proposals Due at 5:00pm EST |
December 18, 2024 | Notification of Funding Decisions |
February 1, 2025 | Grant Period Begins |
September 1, 2025 | Interim Report Due |
January 31, 2026 | Grant Period Ends |
March 1, 2026 | Final Report Due |
View the Pre-Application Webinar video, click here
To download the Pre-Application slide deck, click here.
If you have any questions about this funding opportunity or the content of your pre-application survey, please reach out to Angelo Gomez, Senior Program Manager for Harm Reduction Futures Fund at harmreduction@aidsunited.org. If you have any questions about navigating our online application form or submitting your survey, please contact grants@aidsunited.org
About Harm Reduction Futures Fund: The Harm Reduction Futures Fund strengthens the lifesaving work of syringe services programs nationwide. Its mission remains the same as it was nearly two decades ago: to reduce the health, psychosocial and socioeconomic disparities experienced by people who use drugs. To that end, the fund invests in evidence-based and community-driven approaches to prevent the transmission of both HIV and viral hepatitis, reduce injection-related injuries, increase overdose prevention and reversal efforts and connect people who use drugs to comprehensive prevention, treatment, and support services.